MESOTHELIOMA, MESOTHELIOMA CANCER, MESOTHELIOMA LAWYER, CANCER LAWYER
Tuesday, October 23, 2007
Cancer And Mesothelioma Advisory
Human agonistic trail receptor antibodies mapatumumab and lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
No comments:
Post a Comment